Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm

被引:30
|
作者
Ramos-Mozo, P. [1 ]
Rodriguez, C. [3 ]
Pastor-Vargas, C. [2 ]
Blanco-Colio, L. M. [1 ]
Martinez-Gonzalez, J. [3 ]
Meilhac, O. [5 ]
Michel, J-B [5 ]
Vega de Ceniga, M. [4 ]
Egido, J. [1 ]
Martin-Ventura, J. L. [1 ]
机构
[1] Diaz Autonoma Univ, Vasc Res Lab, Madrid, Spain
[2] Diaz Autonoma Univ, Immunol Lab, IIS Fdn Jimenez, Madrid, Spain
[3] IIB St Pau, Ctr Invest Cardiovasc, Consejo Super Invest Cient, Inst Catalia Ciencies Cardiovasc, Barcelona, Spain
[4] Hosp Galdakao Usansolo, Bilbao, Spain
[5] Univ Paris 07, INSERM, CHU X Bichat, U698, Paris, France
关键词
Biomarkers; Platelets; Thrombosis; Abdominal aortic aneurysm; GROWTH-FACTOR-I; FACTOR-BINDING PROTEIN-1; IGF-I; AGGREGATION; PLATELETS; RELEASE;
D O I
10.1016/j.atherosclerosis.2012.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Cytokines are important mediators of immune-inflammatory responses implicated in abdominal aortic aneurysm (AAA) pathogenesis. Our objective was to investigate the cytokine expression profile in plasma of AAA patients. Methods: Cytokine protein expression was measured in plasma of 5 large AAA patients (aortic size > 50 mm) and 5 controls (aortic size <30 mm) using a 20-cytokine antibody-based protein array. IGFBP-1 plasma concentrations were analyzed by ELISA. IGFBP-1 protein levels were analyzed in AAA thrombus by immunohistochemistry and Western blot. Platelet aggregation was assessed by conventional optical aggregometry. Results: Several proteins including MIP-3alpha (CCL20), Eotaxin-2 and IGFBP-1 were increased in AAA patients compared to controls. Among them, IGFBP-1 concentrations were significantly higher in large AAA patients vs control subjects. These data were validated in plasma of patients with large AAA (n = 30) compared to matched controls (n = 30) [ 834(469-1628) vs 497(204-893) pg/ml, p < 0.01]. Furthermore, the potential association of IGFBP-1 with AAA size was analyzed in a second independent group of subjects [ large AAA (n = 59), small AAA patients (aortic size = 30-50 mm, n = 54) and controls (n = 30)]. Interestingly, IGFBP-1 levels correlated with AAA size (r = 0.4, p < 0.001), which remained significant after adjusting for traditional risk factors. IGFBP-1 was localized in the luminal part of AAA thrombus and IGFBP-1 levels were increased in AAA thrombus conditioned media compared to media layer and healthy media. Interestingly, IGFBP-1 abrogated the potentiation of ADP-induced platelet aggregation triggered by IGF-1. Conclusions: IGFBP-1 has been identified by a protein array approach as a potential novel biomarker of AAA. The biological role of IGFBP-1 in AAA pathogenesis could be related to the modulation on the effect of IGF-1 on platelet aggregation. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:544 / 550
页数:7
相关论文
共 50 条
  • [31] Myeloid related protein 8/14 is a new candidate biomarker and therapeutic target for abdominal aortic aneurysm
    Liu, Peng
    Sun, Ziqiang
    Zhang, Yanhui
    Guo, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [32] Proteomics Analysis of Genetic Liability of Abdominal Aortic Aneurysm Identifies Plasma Neogenin and Kit Ligand: The ARIC Study
    Steffen, Brian T.
    Pankow, James S.
    Norby, Faye L.
    Lutsey, Pamela L.
    Demmer, Ryan T.
    Guan, Weihua
    Pankratz, Nathan
    Li, Aixin
    Liu, Guning
    Matsushita, Kunihiro
    Tin, Adrienne
    Tang, Weihong
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (02) : 367 - 378
  • [33] The role of alpha-1-antitrypsin protein in the pathogenesis of abdominal aortic aneurysm
    Dzeljilji, Agata W.
    Chorostowska-Wynimko, Joanna
    Szewczyk, Dariusz
    Popiolek, Wojciech
    Kierach, Artur
    Andziak, Piotr
    ACTA ANGIOLOGICA, 2018, 24 (01): : 30 - 33
  • [34] Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
    Feridooni, Tiam
    Zamzam, Abdelrahman
    Popkov, Mariya
    Syed, Muzammil H. H.
    Djahanpour, Niousha
    Wheatcroft, Mark
    Abdin, Rawand
    Qadura, Mohammad
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [35] Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
    Tiam Feridooni
    Abdelrahman Zamzam
    Mariya Popkov
    Muzammil H. Syed
    Niousha Djahanpour
    Mark Wheatcroft
    Rawand Abdin
    Mohammad Qadura
    Scientific Reports, 12
  • [36] The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study
    Middleton, Rachel K.
    Lloyd, Geraint M.
    Bown, Matthew J.
    Cooper, Nicola J.
    London, Nicholas J.
    Sayers, Robert D.
    JOURNAL OF VASCULAR SURGERY, 2007, 45 (03) : 574 - 580
  • [37] MicroRNA-155 as a potential plasma non-invasive biomarker for the diagnosis and prognosis of abdominal aortic aneurysm
    Ni, Haizhen
    Lv, Heping
    Qiu, Yihui
    Su, Xiang
    Huang, Jingyong
    Yu, Guanfeng
    Su, Bofeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9340 - 9347
  • [38] The potential role of plasma fibroblast growth factor 21 as a diagnostic biomarker for abdominal aortic aneurysm presence and development
    Xie, Ting
    Yin, Liangying
    Guo, Dan
    Zhang, Zixin
    Chen, Yuexin
    Liu, Bao
    Wang, Wei
    Zheng, Yuehong
    LIFE SCIENCES, 2021, 274
  • [39] Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
    Djureinovic, Dijana
    Ponten, Victor
    Landelius, Per
    Al Sayegh, Sahar
    Kappert, Kai
    Kamali-Moghaddam, Masood
    Micke, Patrick
    Stahle, Elisabeth
    BMC CANCER, 2019, 19 (1)
  • [40] Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
    Dijana Djureinovic
    Victor Pontén
    Per Landelius
    Sahar Al Sayegh
    Kai Kappert
    Masood Kamali-Moghaddam
    Patrick Micke
    Elisabeth Ståhle
    BMC Cancer, 19